Unsure of Medicare Prescribing Rules for Diabetes Testing Supplies?

Free Webinar Offers Straight Answers

November 03, 2016 04:39 pm News Staff

When it comes to the various types of durable medical equipment (DME) family physicians prescribe for their patients, glucose monitors and related diabetes testing supplies are at the top of the list.

[Young businessman working on his laptop in the office, with webinar displayed on screen]

Unfortunately, according to Kent Moore, the AAFP's senior strategist for physician payment, Medicare rules that cover these items "are an ongoing source of frustration for our members."

Physicians who have questions about these items should not hesitate to register for a free webinar(attendee.gotowebinar.com) scheduled for Nov. 8 at 11:30 a.m. CST. Time is short, so register today.

The webinar content targets Medicare Part A and Part B providers as well as DME suppliers.

It is hosted by provider outreach and education representatives from CGS, a Nashville, Tenn.-based company that has partnered with CMS for more than 50 years to provide a variety of services for Medicare beneficiaries and medical equipment suppliers.

Webinar presenters will explain in detail Medicare's coverage criteria for glucose monitors and associated supplies.

In addition, participants will learn what they need to know about documentation requirements, including for medical records, written orders and supply refills.

Time has been set aside for questions and answers at the end of the session.

On a related note, the AAFP has urged CMS to address physicians' concerns with the burdensome Medicare requirements for prescribing glucose monitors and associated supplies.

In an April 18 letter to HHS Secretary Sylvia Burwell, (then) AAFP Board Chair Robert Wergin, M.D., of Milford, Neb., wrote, "In practice, the documentation requirements are onerous to our members and consume valuable physician time that is not germane to the actual care of the patient."

He continued, "Family physicians' time is better spent helping patients manage their diabetes, not providing additional paperwork to justify what the patient needs."

CMS responded with a rare followup request to the AAFP that addressed specific Academy concerns and asked Wergin for additional information and collaboration.